Judkins Brian C
SEC CIK 1823398 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CHE | CHEMED CORP | VP, CLO | 9,222 | $75.3K | $14.39M | 15 | 2023-02-17 | 2026-08-10 |
Most active insiders at CHE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MCNAMARA KEVIN J | Pres, CEO, Dir | — | $7.63M |
| 2 | LINDELL ANDREA R | Dir | — | $602.6K |
| 3 | LEE SPENCER S | EVP | — | $541.0K |
| 4 | WALSH GEORGE J III | Dir | — | $218.9K |
| 5 | GRACE PATRICK P | Dir | — | $126.6K |
| 6 | Wherley Joel L | CEO - Vitas Healthcare | — | — |
| 7 | McCarthy Eileen P | Dir | — | — |
| 8 | Mount John Meredith Jr. | Dir | — | — |
| 9 | Judkins Brian C | VP, CLO | — | — |
| 10 | Heaney Christopher J | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 14:29 | 2026-08-10 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | M - OptEx | $445.35 | +6,786 | 9,222 | +279% | +$3.02M |
| D | 2026-08-10 14:29 | 2026-08-10 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | F - Tax | $548.96 | -5,878 | 3,344 | -64% | -$3.23M |
| DM | 2026-02-17 | 2026-02-13 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | M - OptEx | $469.56 | +351 | 2,538 | +16% | +$164.8K |
| D | 2026-02-17 | 2026-02-13 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | F - Tax | $469.56 | -102 | 2,436 | -4% | -$47.9K |
| DM | 2025-02-18 | 2025-02-14 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | M - OptEx | $553.39 | +724 | 2,234 | +48% | +$400.7K |
| D | 2025-02-18 | 2025-02-14 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | F - Tax | $553.39 | -215 | 2,187 | -9% | -$119.0K |
| 2024-12-30 | 2024-12-30 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | P - Purchase | $519.50 | +145 | 1,678 | +9% | +$75.3K | |
| DMA | 2024-12-20 | 2024-03-20 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | M - OptEx | $443.22 | +12.0K | 12.7K | +1,631% | +$5.30M |
| DA | 2024-12-20 | 2024-03-20 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | S - Sale+OE | $645.00 | -11.2K | 1,533 | -88% | -$7.20M |
| DM | 2024-03-22 | 2024-03-20 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | M - OptEx | $443.22 | +12.0K | 12.6K | +1,923% | +$5.30M |
| D | 2024-03-22 | 2024-03-20 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | S - Sale+OE | $645.00 | -11.2K | 1,422 | -89% | -$7.20M |
| DM | 2024-02-20 | 2024-02-16 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | M - OptEx | $586.49 | +368 | 622 | +145% | +$215.8K |
| D | 2024-02-20 | 2024-02-16 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | F - Tax | $586.49 | -110 | 733 | -13% | -$64.5K |
| DM | 2023-02-22 | 2023-02-17 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | M - OptEx | $515.12 | +587 | 437 | New | +$302.4K |
| D | 2023-02-22 | 2023-02-17 | CHE | CHEMED CORP | Judkins Brian C | VP, CLO | F - Tax | $515.12 | -175 | 475 | -27% | -$90.1K |
Purchase Sale Sale after option exercise All abbreviations